Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Aug 2022 – 20 Aug 2026, limited by quant Large Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant Large Cap Fund | Nifty 100 |
|---|---|---|
| 12 Aug 2022 | ₹100.00 | ₹100.00 |
| 12 Dec 2022 | ₹103.52 | ₹104.09 |
| 14 Apr 2023 | ₹94.43 | ₹98.21 |
| 14 Aug 2023 | ₹107.03 | ₹107.65 |
| 15 Dec 2023 | ₹123.40 | ₹120.26 |
| 15 Apr 2024 | ₹145.10 | ₹127.90 |
| 16 Aug 2024 | ₹154.70 | ₹142.44 |
| 16 Dec 2024 | ₹151.92 | ₹142.86 |
| 17 Apr 2025 | ₹138.49 | ₹135.98 |
| 18 Aug 2025 | ₹148.02 | ₹141.96 |
| 18 Dec 2025 | ₹150.55 | ₹146.60 |
| 20 Apr 2026 | ₹146.95 | ₹140.63 |
| 20 Aug 2026 | ₹158.65 | ₹141.41 |
| Metric | quant · Regular NAV ₹15.88 Very High risk ★★★☆☆ | Category median Large Cap Fund · 35 funds |
|---|---|---|
| +6.02% | -0.15% | |
| +13.73% | +11.26% | |
| — | +9.97% | |
| — | +11.47% | |
| +12.16% | +11.40% | |
| +10.83% | — | |
| +14.68% | +13.21% | |
| — | +12.15% | |
| — | +12.34% | |
| Risk | ||
| 15.96% | 13.29% | |
| 0.45 | 0.34 | |
| 0.63 | 0.47 | |
| -21.60% | -36.99% | |
| Nifty 100 | — | |
| +3.45% | +1.29% | |
| 1.13 | 0.96 | |
| 117.1% | 101.0% | |
| 103.4% | 93.9% | |
| 2.89% | 2.19% | |
| ₹3,172Cr | ₹2,004Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 44% | |
| Sanjeev Sharma | — | |
| 12 Aug 2022 | — | |
| 11 | — | |
| 71.0% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.